Bausch Health Companies Inc. (BHC)
USD 4.34
(0.46%)
USD 4.34
(0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.03 Billion | -728 Million | 1.42 Billion | 1.11 Billion | 1.5 Billion | 1.5 Billion |
| Net Income | -611 Million | -212 Million | -937 Million | -559 Million | -1.78 Billion | -4.14 Billion |
| Depreciation & Amortization | 1.26 Billion | 1.39 Billion | 1.55 Billion | 1.82 Billion | 2.07 Billion | 2.81 Billion |
| Deferred income taxes | 51 Million | -176 Million | -225 Million | -475 Million | -230 Million | -144 Million |
| Stock-based compensation | 132 Million | 126 Million | 128 Million | 105 Million | 102 Million | 87 Million |
| Change in working capital | -582 Million | -396 Million | -128 Million | -366 Million | -318 Million | 18 Million |
| Other non-cash items | 778 Million | -1.46 Billion | 1.03 Billion | 581 Million | 1.65 Billion | 2.86 Billion |
| Investing Cash Flow | -2.14 Billion | -303 Million | 409 Million | -261 Million | -419 Million | -196 Million |
| Investments in PPE | -272 Million | -268 Million | -283 Million | -309 Million | -278 Million | -235 Million |
| Acquisitions | -1.89 Billion | -45 Million | -14 Million | 16 Million | -180 Million | 5 Million |
| Investment purchases | -27 Million | -17 Million | -19 Million | -4 Million | -16 Million | -7 Million |
| Sales/Maturities of investments | 26 Million | 22 Million | 42 Million | 8 Million | 10 Million | 7 Million |
| Other Investing Activities | 18 Million | 5 Million | 683 Million | 28 Million | 45 Million | 34 Million |
| Financing Cash Flow | 1.47 Billion | -474 Million | -1.51 Billion | -2.29 Billion | 1.44 Billion | -1.35 Billion |
| Debt repayment | -1.58 Billion | -7.84 Billion | -3.44 Billion | -5.64 Billion | -4.41 Billion | -10.1 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -24 Million | -31 Million | -52 Million | -30 Million | -40 Million | -10 Million |
| Common Stock Issuance | - | 675 Million | - | - | - | 1.89 Million |
| Other Financing Activities | -106 Million | 6.75 Billion | 1.97 Billion | 3.37 Billion | 5.9 Billion | 8.75 Billion |
| Accounts receivables | -195 Million | -57 Million | -229 Million | 170 Million | 39 Million | 216 Million |
| Accounts payables | 158 Million | -72.02 Million | 121 Million | -471 Million | -149 Million | -568 Million |
| Inventory | -322 Million | -198 Million | -16 Million | -77 Million | -209 Million | -5 Million |
| Other working capital | -223 Million | -68.97 Million | -4 Million | 12 Million | 1 Million | 375 Million |
| Cash at beginning of period | 591 Million | 2.11 Billion | 1.81 Billion | 3.24 Billion | 723 Million | 797 Million |
| Cash at end of period | 962 Million | 591 Million | 2.11 Billion | 1.81 Billion | 3.24 Billion | 723 Million |
| Capital Expenditure | -272 Million | -268 Million | -283 Million | -309 Million | -278 Million | -235 Million |
| Effect of forex changes on cash | 9 Million | -23 Million | -19 Million | 16 Million | -4 Million | -26 Million |
| Net cash flow / Change in cash | 371 Million | -1.52 Billion | 303 Million | -1.42 Billion | 2.52 Billion | -74 Million |
| Free Cash Flow | 760 Million | -996 Million | 1.14 Billion | 802 Million | 1.22 Billion | 1.26 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -116.28 Million | 9.99 Million | -63.71 Million | -47 Million | -611 Million | -382 Million |
| Depreciation & Amortization | 323.49 Million | 317.93 Million | 318.57 Million | 329 Million | 1.26 Billion | 301 Million |
| Deferred income taxes | -3.15 Million | -44.09 Million | -56.74 Million | 84 Million | 51 Million | -3 Million |
| Stock-based compensation | 38 Million | 36 Million | 33 Million | 29 Million | 132 Million | 29 Million |
| Change in working capital | 3.33 Million | 31.51 Million | -34.84 Million | -170 Million | -582 Million | -148 Million |
| Other non-cash items | 165.79 Million | 666.65 Million | 835.25 Million | 165 Million | 778 Million | 485 Million |
| Investing Cash Flow | -102.36 Million | -78.95 Million | -72.67 Million | -148 Million | -2.14 Billion | -1.88 Billion |
| Investments in PPE | -69.34 Million | -79.03 Million | -82.62 Million | -144 Million | -272 Million | -46 Million |
| Acquisitions | -1.99 Million | 1 Million | 995.53 Thousand | -3 Million | -1.89 Billion | -1.85 Billion |
| Investment purchases | -2 Million | -2 Million | -2.98 Million | -14 Million | -27 Million | -2 Million |
| Sales/Maturities of investments | 3.99 Million | 1.03 Million | 5.97 Million | 13 Million | 26 Million | 4 Million |
| Other Investing Activities | -33.01 Million | 43.79 Thousand | 5.97 Million | 27.33 Thousand | 18 Million | 11 Million |
| Financing Cash Flow | -195.13 Million | -423.36 Million | -334.49 Million | -79 Million | 1.47 Billion | 1.81 Billion |
| Debt repayment | -727.87 Million | -414.27 Million | -313.59 Million | -57 Million | -1.58 Billion | -1.87 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 18 Million | -4 Million | -14 Million | -1 Million | -24 Million | -8 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 514.73 Million | -9.08 Million | -20.9 Million | -58 Million | -106 Million | -21 Million |
| Accounts receivables | 177.65 Million | -71.93 Million | -62.71 Million | -19 Million | -195 Million | -231 Million |
| Accounts payables | 144.86 Million | 137.36 Million | 50.77 Million | 97 Million | 158 Million | 164.65 Million |
| Inventory | -41.82 Million | -32.81 Million | -143.35 Million | -100 Million | -322 Million | -62 Million |
| Other working capital | -119.35 Million | -1.1 Million | 120.45 Million | -148 Million | -223 Million | -19.65 Million |
| Cash at beginning of period | 622.9 Million | 754.22 Million | 957.07 Million | 780 Million | 591 Million | 588 Million |
| Cash at end of period | 750 Million | 622.9 Million | 754.22 Million | 962 Million | 962 Million | 780 Million |
| Capital Expenditure | -69.34 Million | -79.03 Million | -82.62 Million | -144 Million | -272 Million | -46 Million |
| Effect of forex changes on cash | 13 Million | -9 Million | -5 Million | 19 Million | 9 Million | -17 Million |
| Net cash flow / Change in cash | 127.09 Million | -131.31 Million | -202.85 Million | 182 Million | 371 Million | 192 Million |
| Free Cash Flow | 341.84 Million | 299.71 Million | 123.44 Million | 246 Million | 760 Million | 236 Million |
LEGN
600649
HWAL
688788
MEDICAMEQ
3880